California Stem Cell Agency's Newest Board Member -- Kevin Xu
The 35-person governing board of the $12 billion California stem cell and gene therapy program has a new member -- Kevin Xu, CEO and chairman of a Beijing-based company, MEBO Group.
Xu was appointed to the board by former Democratic State Assembly Speaker Anthony Rendon before Rendon left office. Xu replaces Al Rowlett of Sacramento…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.